ArticleIsrael journal of health policy research2014
The burden of smoking in Israel-attributable mortality and costs (2014).
Article in Israel journal of health policy research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Building a House on Sand: How Tobacco Use Is Devouring Resources.Addiction & health · 2023Review
- Exposure to respirable and fine dust particle over North-Central India: chemical characterization, source interpretation, and health risk analysis.Environmental geochemistry and health · 2020Article
- Historic tobacco legislation in Israel: a moment to celebrate.Israel journal of health policy research · 2020Article
- The promise - and pitfalls - of smoke-free policy adoption.Israel journal of health policy research · 2019Article
- Knowledge and risk perceptions of Israelis towards combustible cigarettes: the need for immediate remedial action.Israel journal of health policy research · 2019Article
- Exposure to environmental tobacco smoke in non - smoking adults in Israel: results of the second Israel biomonitoring survey.Israel journal of health policy research · 2018Article
- Smoking-Attributable Direct Healthcare Expenditure in Lithuania: A Prevalence-Based Annual Cost Approach.Medicina (Kaunas, Lithuania) · 2018Article
- Global economic cost of smoking-attributable diseases.Tobacco control · 2018Article
- Using All Means to Protect Public Health in Israel From Emerging Tobacco Products.American journal of public health · 2017Article
- Social characteristics associated with disparities in smoking rates in Israel.Israel journal of health policy research · 2016Article
- A smoke-free medical campus in Jerusalem: data for action.Israel journal of health policy research · 2016Article
- Erratum to: The burden of smoking in Israel-attributable mortality and costs (2014).Israel journal of health policy research · 2016Article
- Mortality, hospital days and expenditures attributable to ambient air pollution from particulate matter in Israel.Israel journal of health policy research · 2016Article
- Complying with the framework convention for tobacco control: an application of the Abridged SimSmoke model to Israel.Israel journal of health policy research · 2016Article
- Economic burden of smoking: a systematic review of direct and indirect costs.Medical journal of the Islamic Republic of Iran · 2016Article
- Commentary on a smoke-free medical campus in Jerusalem: data for action.Israel journal of health policy research · 2016Article
- Tobacco policy in Israel: 1948-2014 and beyond.Israel journal of health policy research · 2015Article
- Reducing the burden of tobacco: what's the endgame?Israel journal of health policy research · 2014Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTobacco use is the single most preventable cause of death, incurring huge resource costs in terms of treating morbidity and lost productivity. This paper estimates smoking attributable mortality (SAM) as health costs in 2014 in Israel.
methodsLongitudinal data on prevalence of smokers and ex-smokers were combined with diagnostic and gender specific data on Relative Risks (RR) to gender and disease specific population attributable risks (PAR). PAR was then applied to mortality and hospitalization data from 2011, adjusted by population growth to 2014 to calculate SAM and hospitalization days (SAHD) caused by active smoking. These were used as a base for calculating deaths, hospital days and costs attributable to passive smoking, smoking by pregnant women, residential fires and productivity losses based on international literature.
resultsThe lagged model estimated active SAM in Israel in 2014 to be 7,025 deaths. Cardio-vascular causes accounted for 45.0% of SAM, malignant neoplasms (39.2%) and respiratory diseases (15.5%). Lung cancer alone accounted for 24.1% of SAM. There were an estimated 793, 17 and 12 deaths from passive smoking, mothers-to-be smoking and residential fires. Total SAM is around 7,847 deaths (95% CI 7,698-7,997) in 2014. We estimated 319,231 active SAHD days (95% CI 313,135-325,326). Respiratory care accounted for around one-half of active SAHD (50.5%). Cardio-Vascular causes for 33.5% and malignant neoplasms (13.2%). Lung cancer only for 4.6%. Total SAHD was around 356,601 days including 36,049 days from passive smoking. Estimated direct acute care costs of 356,601 days in a general hospital amount to around 849 (95% CI 832-865) million NIS ($244 million). Non acute care costs amount to an additional 830 million NIS ($238 million). The total health service costs amount to 1,678 million NIS (95% CI 1,646-1,710) or $482 million, 0.2% of GNP. Productivity losses account for a further 1,909 million NIS ($548 million), giving an overall smoking related cost of 3,587 million NIS (95% CI 3,519-3,656) or $1,030 million, 0.41% of GNP).
conclusionsSmoking causes a considerable burden in Israel, both in terms of the expected 7,847 lives lost and the financial costs of around 3.6 million NIS ($1,030 million or 0.42% of GNP).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.